SCHEMBL7465706

SCHEMBL7465706

Fc1ccccc1Cn1cccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
PKM P14618 1/20 0.54
CYP19A1 P11511 1/20 0.46
BRD4 O60885 1/20 0.45
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30047375 1.00 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL28806287 0.86 BRD4 (0.43) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL18405111 0.83 KDM4E (0.45) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL14822759 0.81 RIPK1 (0.44) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL14822757 0.81 CYP3A4 (0.48) ALDH1A1KMT2AMEN1MAPTCYP19A1
SCHEMBL27407526 0.79 BRD4 (0.46) ALDH1A1KMT2AMEN1MAPTBRD4
SCHEMBL3809851 0.78 TP53 (0.45) MAPTBRD4CYP3A4CYP2C9GAA
SCHEMBL1953678 0.78 BRD4 (0.43) KMT2AMEN1MAPTBRD4CYP1A2
SCHEMBL2202098 0.78 GAA (0.50) KMT2AMEN1MAPTL3MBTL1CYP19A1
SCHEMBL30364150 0.78 GAA (0.50) KMT2AMEN1MAPTL3MBTL1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017025981-A1 PROCESS FOR THE PREPARATION OF METHYL 4,6-DIAMINO-2-[L-(2-FHIOROBENZVR)-LH-PYRAZOLO I3,4-BLPVRIDIN-3-VN-5-PYRIMIDINYL(METHVL)CARBAMATE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-02-16 WO claimed
CN-1845918-A Pyrimidines useful as modulators of voltage-gated ion channels VERTEX PHARMA (US) 2006-10-11 CN claimed
CN-117466890-A Preparation method of antithrombotic disease drug intermediate 安徽美诺华药物化学有限公司 2024-01-30 CN disclosed
WO-2020164008-A1 PROCESS FOR THE PREPARATION OF POROUS MICROPARTICLES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-20 WO disclosed
CN-110267949-A SGC stimulant 塞科里昂医疗股份有限公司 2019-09-20 CN disclosed
US-10414766-B2 Polymorph of Riociguat and its process for the preparation ALEMBIC PHARMACEUTICALS LIMITED (IN) 2019-09-17 US disclosed
US-20190002461-A1 NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION ALEMBIC PHARMACEUTICALS LIMITED (IN) 2019-01-03 US disclosed
WO-2017107052-A1 SOLUBLE GUANYLATE CYCLASE STIMULATORS MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed
WO-2017025981-A1 PROCESS FOR THE PREPARATION OF METHYL 4,6-DIAMINO-2-[L-(2-FHIOROBENZVR)-LH-PYRAZOLO I3,4-BLPVRIDIN-3-VN-5-PYRIMIDINYL(METHVL)CARBAMATE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-02-16 WO disclosed
US-20160106102-A1 KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-04-21 US disclosed
EP-2802587-A2 SUBSTITUTED, ANNULATED IMIDAZOLES AND PYRAZOLES, AND USE THEREOF Bayer Intellectual Property GmbH (DE) 2014-11-19 EP disclosed
CN-100506825-C Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors WYETH CORP (US) 2009-07-01 CN disclosed
CN-101189010-A Tricyclic 6-alkylidene-penems as class D beta-lactamase inhibitors WYETH CORP (US) 2008-05-28 CN disclosed
CN-1845918-A Pyrimidines useful as modulators of voltage-gated ion channels VERTEX PHARMA (US) 2006-10-11 CN disclosed
CN-1649882-A Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors WYETH CORP (US) 2005-08-03 CN disclosed
EP-1102768-A1 SUBSTITUTED PYRAZOLE DERIVATIVES CONDENSED WITH SIX-MEMBERED HETEROCYCLIC RINGS Bayer Aktiengesellschaft (DE) 2001-05-30 EP disclosed
EP-1102767-A1 SUBSTITUTED PYRAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2001-05-30 EP disclosed
WO-2000066582-A1 SUBSTITUTED PYRAZOLE DERIVATIVE BAYER AKTIENGESELLSCHAFT (DE) 2000-11-09 WO disclosed
WO-2000006568-A1 SUBSTITUTED PYRAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2000-02-10 WO disclosed
WO-2000006569-A1 SUBSTITUTED PYRAZOLE DERIVATIVES CONDENSED WITH SIX-MEMBERED HETEROCYCLIC RINGS BAYER AKTIENGESELLSCHAFT (DE) 2000-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002461-A1 NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION RIOK1, RIOK2, RIOK3 ALDH1A1 1256/4885KMT2A 3182/4885MEN1 4510/4885
US-10414766-B2 Polymorph of Riociguat and its process for the preparation RIOK2, RIOK1, RIOK3 ALDH1A1 1176/4885KMT2A 3346/4885MEN1 4435/4885
US-20160106102-A1 KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS DDT, ACHE, NISCH ALDH1A1 2634/4885KMT2A 831/4885MEN1 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.